IDRI and Jubilant Chemsys extend research for TB drug discovery
The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
New phase III psoriasis data show significant skin clearance with Novartis’ secukinumab
Patient-reported outcomes from Feature and Juncture show high patient satisfaction with secukinumab PFS and AI self-administration…
Urgent action needed to prevent unregulated sale of TB drugs in India: MSF
Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India
US FDA approves Piramal Imaging’s Neuraceq
Will help in PET imaging of beta-amyloid neuritic plaques in the brain
Lupin launches Generic Niaspan tablets in the US
To reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed…
Cutting-edge TB diagnostic test now available at reduced price
Faster and more accurate Liquid Culture Test gains increased acceptance
Pharma hub has shifted towards Goa
Goa FDA's consistent efforts have made the state a favourite destination for domestic as well as the global pharma industry. Salim…
New Goa FDA office
Manohar Parrikar, Chief Minister, Goa, inaugurated Goa FDA’s new building in Bambolim
Advantage Goa
From being tourist attraction for its beautiful and scenic beaches, Goa is slowly becoming the Mecca of Indian pharma industry
Our administration generated positive, vibrant environment for pharma sector
Gujarat Food and Drug Control Administration (FDCA) has been striving for the growth and regulation of the pharmaceutical industry…